In situ PCR analysis of tumor-infiltrating lymphocytes illustrated in Fig 1d through f. The neo gene was detected in 1% of the infiltrating lymphocytes, a rate that corresponds to the gene-marking efficiency for the EBV-specific T-cell line administered to this patient.